Open Label Extension In Cancer Patients
NCT00830180
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Bone Metastases
Interventions
BIOLOGICAL:
Anti-NGF AB
Sponsor
Pfizer